Maximum quantity allowed is 999
Please select the quantity
CAS RN: 302-95-4 | Product Number: C0316
Sodium Deoxycholate
Purity: >98.0%(T)
Synonyms:
- Choleic Acid Sodium Salt
- Deoxycholic Acid Sodium Salt
- Sodium Choleate
Product Documents:
Size | Unit Price | Same Day | 2-3 Business Days |
---|---|---|---|
100G |
A$440.00
|
35 | ≥100 |
* Please contact our distributor of Chem-Supply
if you would like to purchase TCI products. The above prices do not include freight cost, customs charge and other charges to the destination.
* ChemSupply Australia Pty Ltd (Phone: 08-8440-2000 / email: sales@chemsupply.com.au)
* ChemSupply Australia Pty Ltd (Phone: 08-8440-2000 / email: sales@chemsupply.com.au)
Product Number | C0316 |
Purity / Analysis Method | >98.0%(T) |
Molecular Formula / Molecular Weight | C__2__4H__3__9NaO__4 = 414.56 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Hygroscopic |
CAS RN | 302-95-4 |
Reaxys Registry Number | 6472196 |
Merck Index (14) | 2899 |
MDL Number | MFCD00064139 |
Specifications
Appearance | White to Almost white powder to crystaline |
Purity(Nonaqueous Titration) | min. 98.0 %(calcd.on anh.substance) |
Specific rotation [a]20/D | +41.0 to +45.0 deg(C=2, H2O) |
Solubility in Water | almost transparency |
Water | max. 5.0 % |
Properties (reference)
Specific Rotation | 42° (C=2,H2O) |
Solubility in water | Soluble |
GHS
Pictogram | |
Signal Word | Warning |
Hazard Statements | H302 : Harmful if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
RTECS# | FZ2250000 |
Transport Information:
H.S.code* | 2918.19-000 |
Application
Reagent for inflammation model
References
- Increased activity of group II phospholipase A2 in plasma in rat sodium deoxycholate induced acute pancreatitis
- Ursodeoxycholic acid prevents hepatic cytochrome P450 isozyme reduction in rats with deoxycholic acid-induced liver injury
- A rat model of chronic postinflammatory visceral pain induced by deoxycholic acid
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.
Other Documents
Maximum quantity allowed is 999
Please select the quantity